$bluebird bio (BLUE.US)$
Failed $4.50 Bid: bluebird bio Stands Firm on Carlyle Deal as Ayrmid Misses Deadline

$bluebird bio (BLUE.US)$ till one day we need this one badly.. Maybe 10 years later 🤔

$bluebird bio (BLUE.US)$ Carlyle and SK Capital Partners announced the extension of their tender offer for bluebird bio from April 4 to April 18, 2025. The extension aims to allow additional time for satisfying remaining conditions, including regulatory approvals. As of April 2, approximately 65,120 shares have been validly tendered.
The offer includes $3.00 in cash per share plus one contingent value right (CVR) representing a potential additional payment of $6.84 per share, subjec...

$bluebird bio (BLUE.US)$
🚀🚀

$bluebird bio (BLUE.US)$ Reuters· just
Xcellbio: Granted bluebird bio Commercial License, Got Into Supply Agreement for Use of Co's Proprietary Cell Manufacturing Technology, Avatar

Here are the levels to watch as Blue pushes higher.
$bluebird bio (BLUE.US)$  

$bluebird bio (BLUE.US)$ close my eyes it'll rise

$bluebird bio (BLUE.US)$ damn i didnt buy it when 4.6

$bluebird bio (BLUE.US)$
🚀😉

$bluebird bio (BLUE.US)$
good earning recently with a little bump 👀